Last Price Today's Change   Day's Range   Trading Volume
0.105   0.00 (0.00%)  0.00 - 0.00  0
Analyze this stock with MQ Trader system


Market Cap: 56 Million
NOSH: 535 Million
Avg Volume (4 weeks):51,160
4 Weeks Range:0.10 - 0.14
4 Weeks Price Volatility (%):
52 Weeks Range:0.075 - 0.20
52 Weeks Price Volatility (%):
Average Price Target: 0.54
Price Target Upside/Downside: +0.435

Financial Highlight

Latest Quarter | Ann. Date 30-Sep-2019 [#3]  |  28-Nov-2019
Next QR | Est. Ann. Date: 31-Dec-2019  |  28-Feb-2020
T4Q P/E | EY: -3.95  |  -25.29%
T4Q DY | Payout %: 0.00%  |  - %
T4Q NAPS | P/NAPS: 0.187  |  0.56
T4Q NP Margin | ROE: -5.23%  |  -14.20%


Date Subject
05-Jul-2019 PublicInvest Research Headlines - 5 Jul 2019
05-Jul-2019 Mplus Market Pulse - 5 Jul 2019
16-Jun-2019 Sunzen Biotech Berhad (KLSE) #RTable - CashRich Series - YAPSS

Business Background

Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates through two divisions. The Manufacturing division is involved in the manufacturing and marketing of animal health products such as orgacids, zenacids, om, pfactor, and pfi-lyte. In addition, it also produces palm oil products such as powder fats for livestock animals. The Trading division includes the distribution and marketing of veterinary pharmaceuticals and animal vaccines, and detergent and disinfectant products such as shift, lindores and gpc 8.
Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.

  5 people like this.
Smallstar Ok Duit sifu..tq for your guidance~~ :)
09/07/2018 10:30 PM
ezmoney waa duit sifu back in sunzen..got hope liao la
10/07/2018 1:34 PM
yoon Just bought 0.2.
06/08/2018 8:12 PM
pampers Hopefully the push for this round can last longer...
10/08/2018 9:07 AM
Jordan Khoo 天天提升
10/08/2018 11:29 AM
Smallstar Any good news coming soon? :)
10/08/2018 2:13 PM
yoon Sold 0.25. So happy :)
10/08/2018 4:33 PM
Russell back to being profitable!
24/08/2018 10:39 PM
Russell palm oil suffering now
Sunzen trying to find new revenue
26/08/2018 5:50 PM
Russell high revenue but low profit/incur loss on trading palm oil. What are your thoughts duit?
26/08/2018 7:12 PM
Alex™ Funding for myvi 4 tayar...hehe
26/08/2018 7:21 PM
Alex™ Can sailang tmr? Will up?
26/08/2018 7:21 PM
chyeoh1972 i am still waiting 0.195 to buy back...not buyer not momentum...if can get... will keep for year end divieng
31/08/2018 12:53 PM
Russell Dead stock
24/09/2018 10:57 AM
鹅麟依旧≈ 扫地僧 Sunzen.

Please wake up. Don't die so fast
02/01/2019 9:59 PM
paperplane Hehe
02/01/2019 10:02 PM
鹅麟依旧≈ 扫地僧 Keep buying.

Give me two years to become Top 50 major shareholder
02/01/2019 10:03 PM
鹅麟依旧≈ 扫地僧 Hope volume come after CPO strong.

Good news from India to cushion CPO price
02/01/2019 10:15 PM
鹅麟依旧≈ 扫地僧 Must not die now.....

Faster wake up.. We are in the HCU wad....
03/01/2019 1:48 PM
pampers Duit, WB is a gone case?
03/01/2019 3:28 PM
鹅麟依旧≈ 扫地僧 WB confirm gone case. I lose much at WB also

Sunzen mother just out from HCU. Move to ICU today

Wake. Up pls. Don't die first
03/01/2019 11:03 PM
4444 QR loss why move?
15/01/2019 3:39 AM
PeterNg89 Post removed. Why?
15/01/2019 3:52 AM
鹅麟依旧≈ 扫地僧 Why



15/01/2019 10:28 AM
commonsense Revenue increase significantly since 1Q17 when the company decided to venture into the trading of palm oil products which has since deliver higher revenue compared to the company’s original business of selling animal health products. This has helped increase the company profit to shareholder to RM3.5mil in FY17 from a loss of RM100k in FY16.

Then in mid FY17, management had proposed to diversify the company into the business of Chinese medicine via the acquisition of 70% of Ecolite Biotech for RM12.1mil. This acquisition was supposed to help increase the profit of the group by around RM1.8mil annually. The acquisition was completed in May 2018. However, based on the 3Q18 result, it does not seem that the acquisition had delivered on the expected profit expected by the shareholders. The newly acquired business posted a loss of RM500k in 3Q18.

Please take note, that the core losses in 3Q18 is actually around -RM5mil (after stripping out the gain from negative goodwill of RM3.6mil) and not the reported -RM1.4mil. All of the company’ s divisions fail to report any profit for the quarter.

Given the compression of profit margins seen in 3Q18 for all of the company’s main division (animal health products, palm oil trading and Chinese medicine), investors have to be prepared to see further losses in 4Q18 and potentially in the most part of FY19 as well.

If you are looking to diversify your portfolio outside of Sunzen (due to its weak earnings outlook), I would recommend you to look at MBMR.

MBMR is a direct proxy to Perodua via its 22.6% interest in the company. Valuation is cheap at only 6.9x PE (based on target FY18 profit of RM145mil. 9m profit is already RM106mil). PB is low at only 0.7x BV. 4Q18 results is expected to be higher than 3Q18 and last year's 4Q17.

FY19 growth will be driven by the still high demand of the new Myvi and the newly launched SUV Aruz and also the newly revamp Alza in 2H19. The recent announcement of closure and potential disposal of the loss-making alloy wheel manufacturing business alone is expected to boost the company’s profit by an additional RM20mil. I am projecting a profit to shareholder of RM170 mil for FY19 which at the current price values MBMR at only 5.9x PE.

Please go through the analyst reports (https://klse.i3investor.com/servlets/stk/pt/5983.jsp) and do your own analysis before making any decisions. There are 8 analysts in total covering the stock with most of them having a TP of above RM3 (all have a buy rating). The average TP for the 8 analysts is around RM3.50.

Good luck.
06/02/2019 8:10 AM
鹅麟依旧≈ 扫地僧 Yes. This is the 2019 BaBI action from now on
06/02/2019 6:37 PM
Shinnzaii hmm...4th quarter revenue might be better?hehe
13/02/2019 11:50 AM
鹅麟依旧≈ 扫地僧 Whole year net loss RM6. 9 million...

Tomorrow waterfall and also limit down....

No eyes see
28/02/2019 6:05 PM
Shinnzaii There is allowance of impairment for machinery of 6mil...consider separately still okay...next quarter cash outflow might be more larh due to purchase of land with 12mil...
28/02/2019 6:44 PM
鹅麟依旧≈ 扫地僧 Faster plunge. I will consider to add
01/03/2019 9:02 AM
Russell Duit you still have faith in Sunzen after its losses?
01/03/2019 9:30 AM
鹅麟依旧≈ 扫地僧 U see Sunzen down so badly. I better buy more because its cheap
01/03/2019 10:23 AM
鹅麟依旧≈ 扫地僧 Sunzen crash from now on....
05/03/2019 7:20 PM
鹅麟依旧≈ 扫地僧 I will follow you Mr. MD and CEO
06/03/2019 8:40 AM
pampers As predicted, one day show just as usual
06/03/2019 7:24 PM
here Trading of oil palm is not working, it is just for the revenue to look good.
17/04/2019 10:17 AM
here Ecolite store now available on Shopee
22/04/2019 2:39 PM
lone216 Dead fish stock....
23/04/2019 10:43 AM
here Growth of revenue is better to be in line with profit. There is no point to trade Palm Oil with over 70, 80 or 100mil revenue and got net loss or 0.1% profit for every quarter. The revenue also inconsistent. There is no need for the BOD to brag about revenue increased double triple digits due to this.
29/04/2019 11:56 PM
here Current BODs/Senior Management very weak, have no experience and no relation in Animal Health or entire business operation except for Lin Hong Kong(General Manager). Unlike previous owner Dr. Tan Kim Sing who co-founded Sunzen, had more than 20 years experience in animal health or in sales and marketing.

Maybe Datuk Hong (CEO) "Datuk" title is just for show. Since 2014 the animal health did not grow much. Doubt that hIs knowledge in ICT and Interior design going to help Sunzen.

With Madam Ooi currently resigned. The Board only left 3 person..Hope they get someone with good expertise.

Also can consider Mr Chum Mun Cuan (from Ecolite) a try in Board.
15/05/2019 11:20 PM
YAPSS Hey! Today, R-Table will be covering Sunzen Biotech Berhad by presenting 10 years financial results in a short, fun & interesting way. Click the link below to watch the video.

Link: https://youtu.be/BsiGr1lSYmM
#YAPSS #RTable #SunzenBiotechBerhad #CashRichSeries
15/06/2019 6:47 PM
moneykj Kanger. Go for Kanger.
02/08/2019 10:49 AM
鹅麟依旧≈ 扫地僧 Is time for new race
09/08/2019 12:50 AM
here Cannot get profit still want to buy real estate using bank loan, when cannot pay back sure they going to ask shareholder to pay. Share price have reached lowest, closure of retail outlets going to reduce operating costs(let us see whether next quarter can get profit or CEO will create another fairytale stories).

Disposal of Amplio not because of Amplio can't reach profit guarantee, it is caused by the weak CEO and BOD. Amplio is also not in line with the board vision which is to get above 50mil revenue in a blink of an eye without giving any effort just like the Palm Oil trading.

No Profit no problem, Very high revenue is enough.

Failure to compete with Peterlabs and Rhonema.

It is sad to see a good business such as Ecolite falls under a bad holding company.
26/08/2019 3:34 PM
Yuming My money stucked here,,,,shall it rebound?
26/08/2019 5:45 PM
Yuming how how.......seem like oh lin ler
06/09/2019 12:29 PM
Yuming it still alive!!!!! wao...
12/09/2019 3:27 PM
OngKawKaw Sendiri shiok shiok
10/10/2019 1:54 PM
鹅麟依旧≈ 扫地僧 Ya lo.. Shiok shiok
11/10/2019 8:32 AM
kyosan guys...oil palm stock hot right now right~.... why not hoot this Sunzen liao~ their trading crude oil palm oil already 75% contribute total revenue.... so...price increase..then this sunzen will get more profit... u can check their qtr rslt... peace~ happy trading~ don't goreng too much~ :p
12/11/2019 2:29 PM


175  139  428  1521 

Top 10 Active Counters
 DBE 0.035+0.005 
 DYNACIA-PA 0.0450.00 
 DYNACIA 0.0850.00 
 HSI-H8F 0.075-0.05 
 XDL 0.115+0.005 
 ARMADA 0.485+0.02 
 SAPNRG 0.265+0.005 
 AT 0.050.00 
 EKOVEST 0.825+0.015 
 HSI-C7J 0.115+0.03 


1. Leveraged & Inverse ETF CMS
Partners & Brokers